Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Bakris, George
One or more keywords matched the following items that are connected to
Bakris, George
Item Type
Name
Concept
Spironolactone
Academic Article
Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
Academic Article
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
Academic Article
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
Academic Article
Spironolactone for resistant hypertension--hard to resist?
Academic Article
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
Academic Article
Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease.
Academic Article
Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.
Academic Article
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD Trial.
Academic Article
Evolution of Patiromer Use: a Review.
Academic Article
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine.
Academic Article
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists.
Academic Article
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
Search Criteria
Spironolactone